As Teva Pharmaceutical Inds LTD Sponsored Adr (TEVA) Share Value Declined, M Holdings Securities Lowered Its Holding; Seatown Holdings Position In Alexion Pharmaceuticals (ALXN) Was Has Upped

May 21, 2018 - By Vivian Park

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Logo

Seatown Holdings increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 428.57% based on its latest 2017Q4 regulatory filing with the SEC. Seatown Holdings bought 90,000 shares as the company’s stock declined 8.80% with the market. The institutional investor held 111,000 shares of the health care company at the end of 2017Q4, valued at $13.27 million, up from 21,000 at the end of the previous reported quarter. Seatown Holdings who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be bullish on the $26.62B market cap company. The stock decreased 1.19% or $1.44 during the last trading session, reaching $119.63. About 270,328 shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 8.84% since May 21, 2017 and is downtrending. It has underperformed by 20.39% the S&P500.

M Holdings Securities Inc decreased its stake in Teva Pharmaceutical Inds Ltd Sponsored Adr (TEVA) by 53.86% based on its latest 2017Q4 regulatory filing with the SEC. M Holdings Securities Inc sold 15,232 shares as the company’s stock declined 11.04% with the market. The institutional investor held 13,050 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $389,000, down from 28,282 at the end of the previous reported quarter. M Holdings Securities Inc who had been investing in Teva Pharmaceutical Inds Ltd Sponsored Adr for a number of months, seems to be less bullish one the $21.54B market cap company. The stock decreased 0.38% or $0.08 during the last trading session, reaching $21.15. About 3.09 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 49.50% since May 21, 2017 and is downtrending. It has underperformed by 61.05% the S&P500.

More recent Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) news were published by: Nasdaq.com which released: “3 Top Healthcare Stocks to Buy Right Now” on May 01, 2018. Also Benzinga.com published the news titled: “Benzinga’s Insider Buys Of The Week: Alexion Pharmaceuticals, Sohu.com And More” on May 06, 2018. Streetinsider.com‘s news article titled: “Vertex Pharma (VRTX), Alexion Pharma (ALXN) Least Impacted from Trump Drug Policies – RBC” with publication date: May 15, 2018 was also an interesting one.

Among 29 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 25 have Buy rating, 0 Sell and 4 Hold. Therefore 86% are positive. Alexion Pharmaceuticals Inc. had 110 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was initiated by Wedbush with “Neutral” on Friday, September 23. Nomura maintained Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Monday, March 19 with “Buy” rating. The firm earned “Overweight” rating on Thursday, May 25 by Morgan Stanley. The firm earned “Hold” rating on Friday, June 23 by Robert W. Baird. The company was initiated on Thursday, April 7 by BMO Capital Markets. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, May 8 report. Credit Suisse initiated it with “Neutral” rating and $201 target in Wednesday, January 20 report. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, June 23. As per Monday, December 18, the company rating was upgraded by Robert W. Baird. The firm earned “Buy” rating on Wednesday, September 13 by Leerink Swann.

Investors sentiment decreased to 1.03 in 2017 Q4. Its down 0.14, from 1.17 in 2017Q3. It fall, as 65 investors sold ALXN shares while 171 reduced holdings. 64 funds opened positions while 178 raised stakes. 204.38 million shares or 1.21% less from 206.89 million shares in 2017Q3 were reported. Amundi Pioneer Asset Mgmt reported 0.27% stake. Etrade Cap Ltd Liability Co invested in 0.05% or 13,736 shares. Louisiana State Employees Retirement Systems invested in 13,500 shares. Private Trust Na invested in 7,909 shares or 0.2% of the stock. Fmr Limited Com owns 17.67 million shares for 0.25% of their portfolio. Tiaa Cref Mgmt Limited Liability Co holds 3.84M shares. Price T Rowe Assocs Md reported 21.01M shares or 0.41% of all its holdings. Ls Investment Advsrs Ltd Liability has 6,776 shares for 0.05% of their portfolio. Commonwealth Bancorp Of Australia reported 221 shares stake. Banque Pictet And Cie Sa holds 81,220 shares or 0.19% of its portfolio. Grandfield And Dodd Ltd Liability has invested 0.05% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). 57,516 were accumulated by Bluemountain Capital Mngmt Ltd. Point72 Asset Mgmt Limited Partnership owns 222,737 shares for 0.11% of their portfolio. Sterling Capital Ltd Liability reported 0.01% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Conning holds 5,130 shares.

Since January 2, 2018, it had 1 buying transaction, and 12 selling transactions for $3.41 million activity. Another trade for 698 shares valued at $83,305 was sold by Wagner Heidi L. $147,865 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was sold by Moriarty John B. On Tuesday, February 6 the insider Clancy Paul J sold $707,048. Another trade for 10,000 shares valued at $1.21M was bought by COUGHLIN CHRISTOPHER J. Franchini Indrani Lall had sold 1,459 shares worth $169,696 on Tuesday, February 6. Shares for $310,521 were sold by HANTSON LUDWIG.

Seatown Holdings, which manages about $1.06 billion US Long portfolio, decreased its stake in Alibaba Group Hldg Ltd (NYSE:BABA) by 32,850 shares to 173,910 shares, valued at $29.99M in 2017Q4, according to the filing. It also reduced its holding in Bank Amer Corp (NYSE:BAC) by 210,000 shares in the quarter, leaving it with 209,000 shares, and cut its stake in Alphabet Inc.

M Holdings Securities Inc, which manages about $733.83 million and $332.54M US Long portfolio, upped its stake in Gabelli Multimedia Tr Inc Com (GGT) by 21,866 shares to 44,669 shares, valued at $2.47 million in 2017Q4, according to the filing. It also increased its holding in First Tr Exchange (FPE) by 28,370 shares in the quarter, for a total of 123,420 shares, and has risen its stake in Danaher Corp Del Com (NYSE:DHR).

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 153 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Hold” rating by Oppenheimer on Wednesday, October 4. The stock has “Underperform” rating by Credit Suisse on Thursday, August 24. As per Thursday, June 22, the company rating was maintained by Cantor Fitzgerald. As per Thursday, January 11, the company rating was upgraded by Goldman Sachs. The company was maintained on Monday, November 14 by RBC Capital Markets. The rating was upgraded by BTIG Research on Monday, September 11 to “Buy”. The firm has “Hold” rating by Deutsche Bank given on Friday, November 3. The firm earned “Buy” rating on Wednesday, November 16 by Maxim Group. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Hold” rating by Guggenheim on Tuesday, January 16. RBC Capital Markets maintained the stock with “Buy” rating in Friday, June 16 report.

More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Fool.com which released: “Why Teva Pharmaceutical Industries, Gramercy Property Trust, and Medtronic Jumped Today” on May 07, 2018, also Seekingalpha.com with their article: “Teva: Israeli Judge Delays Layoffs At Ashdod Plant” published on April 30, 2018, Investorplace.com published: “Teva Pharmaceutical Industries Ltd, Once a Falling Machete, Is Spiking — Chase It” on May 16, 2018. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: Seekingalpha.com and their article: “Three Teva directors to leave board” published on April 26, 2018 as well as Fool.com‘s news article titled: “Buffett Gets Even Greedier With Teva Pharmaceuticals. Time to Buy?” with publication date: May 18, 2018.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Vivian Park

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: